Michael Evangelopoulos
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
- Biomaterials 18
- Nanoparticle-Based Drug Delivery 16
- Immunology 14
- Immunotherapy and Immune Responses 10
- Co-authors
- Ennio TasciottiJonathan O. MartinezAlessandro ParodiIman K. YazdiClaudia CorboMauro FerrariBrandon BrownRoberto Molinaro
- Journals
- Scientific Reports (4 papers)Journal of the American Chemical Society (4 papers)Biomaterials (4 papers)Nanomedicine (3 papers)Small (3 papers)
- Partner nations
- United StatesItalyMexico
In The Last Decade
Michael Evangelopoulos
51 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Biomaterials 1.3k
- Biomedical Engineering 1.7k
- Immunology 553
- Molecular Biology 1.7k
- Pharmaceutical Science 112
Countries citing papers authored by Michael Evangelopoulos
This map shows the geographic impact of Michael Evangelopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Evangelopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Evangelopoulos more than expected).
Fields of papers citing papers by Michael Evangelopoulos
This network shows the impact of papers produced by Michael Evangelopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Evangelopoulos. The network helps show where Michael Evangelopoulos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Evangelopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 12 | |
| 2 | 2023 | 69 | |
| 3 | 2023 | 7 | |
| 4 | 2022 | 19 | |
| 5 | 2021 | 41 | |
| 6 | 2021 | 71 | |
| 7 | 2021 | 44 | |
| 8 | 2020 | 19 | |
| 9 | 2020 | 20 | |
| 10 | 2020 | 17 | |
| 11 | 2018 | 11 | |
| 12 | 2018 | 100 | |
| 13 | 2017 | 71 | |
| 14 | 2017 | 51 | |
| 15 | 2016 | 64 | |
| 16 | 2015 | 49 | |
| 17 | 2015 | 30 | |
| 18 | 2015 | 37 | |
| 19 | 2014 | 26 | |
| 20 | 2012 | 40 |
About Michael Evangelopoulos
Michael Evangelopoulos is a scholar working on Biomaterials, Immunology, Biomedical Engineering, Molecular Biology and Cancer Research, having authored 51 papers that have together received 3.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (22 papers), Nanoplatforms for cancer theranostics (17 papers), Nanoparticle-Based Drug Delivery (16 papers), Advanced biosensing and bioanalysis techniques (13 papers), Immunotherapy and Immune Responses (10 papers), Extracellular vesicles in disease (9 papers), MicroRNA in disease regulation (4 papers) and Graphene and Nanomaterials Applications (4 papers). The work is most often cited by research in Biomaterials (1.3k citations), Biomedical Engineering (1.7k citations), Immunology (553 citations), Molecular Biology (1.7k citations) and Pharmaceutical Science (112 citations). Michael Evangelopoulos has collaborated with scholars based in United States, Italy and Mexico. Frequent co-authors include Ennio Tasciotti, Jonathan O. Martinez, Alessandro Parodi, Iman K. Yazdi, Claudia Corbo, Mauro Ferrari, Brandon Brown, Roberto Molinaro, Francesca Taraballi and Ciro Chiappini. Their work appears in journals such as Scientific Reports, Journal of the American Chemical Society, Biomaterials, Nanomedicine and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.